EP2054066A4 - Verfahren zur behandlung von strahlenenteritis - Google Patents
Verfahren zur behandlung von strahlenenteritisInfo
- Publication number
- EP2054066A4 EP2054066A4 EP07836488A EP07836488A EP2054066A4 EP 2054066 A4 EP2054066 A4 EP 2054066A4 EP 07836488 A EP07836488 A EP 07836488A EP 07836488 A EP07836488 A EP 07836488A EP 2054066 A4 EP2054066 A4 EP 2054066A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- radiation exposure
- treating enteritis
- enteritis caused
- caused
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cell Biology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL07836488T PL2054066T3 (pl) | 2006-08-02 | 2007-08-02 | Sposoby leczenia popromiennego zapalenia jelit |
| SI200731674T SI2054066T1 (sl) | 2006-08-02 | 2007-08-02 | Postopki za zdravljenje radiacijskega enteritisa |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83527306P | 2006-08-02 | 2006-08-02 | |
| US85029906P | 2006-10-06 | 2006-10-06 | |
| PCT/US2007/017379 WO2008016708A2 (en) | 2006-08-02 | 2007-08-02 | Methods for treatment of radiation enteritis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP2054066A2 EP2054066A2 (de) | 2009-05-06 |
| EP2054066A4 true EP2054066A4 (de) | 2011-01-05 |
| EP2054066B1 EP2054066B1 (de) | 2015-04-15 |
Family
ID=38997731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07836488.2A Not-in-force EP2054066B1 (de) | 2006-08-02 | 2007-08-02 | Verfahren zur behandlung von strahlenenteritis |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2054066B1 (de) |
| JP (3) | JP5844961B2 (de) |
| KR (2) | KR20150132214A (de) |
| CN (1) | CN104382900A (de) |
| AU (1) | AU2007281413B2 (de) |
| BR (1) | BRPI0714724A8 (de) |
| CA (1) | CA2659874C (de) |
| DK (1) | DK2054066T3 (de) |
| ES (1) | ES2538478T3 (de) |
| HU (1) | HUE025306T2 (de) |
| IL (1) | IL196843A (de) |
| MX (1) | MX2009001342A (de) |
| PL (1) | PL2054066T3 (de) |
| PT (1) | PT2054066E (de) |
| SI (1) | SI2054066T1 (de) |
| WO (1) | WO2008016708A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| JP5844961B2 (ja) * | 2006-08-02 | 2016-01-20 | サリックス ファーマシューティカルズ， インコーポレイテッド | 放射線直腸ｓ状結腸炎を処置するための組成物および方法 |
| DK2327407T3 (da) | 2008-09-26 | 2014-08-25 | Aska Pharm Co Ltd | Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme |
| US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| SMT202400116T1 (it) | 2008-10-02 | 2024-05-14 | Salix Pharmaceuticals Ltd | Trattamento dell’encefalopatia epatica utilizzando rifaximina |
| US12285414B2 (en) | 2008-10-02 | 2025-04-29 | Salix Pharmaceuticals, Inc. | Methods of treating hepatic encephalopathy |
| US8916193B2 (en) * | 2008-12-10 | 2014-12-23 | Cipla Limited | Rifaximin complexes |
| US20110294726A1 (en) * | 2009-02-11 | 2011-12-01 | Cedars-Sinai Medical Center | Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome |
| MX348670B (es) | 2009-02-11 | 2017-06-23 | Cedars Sinai Medical Center | Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni. |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| KR102203568B1 (ko) | 2012-09-17 | 2021-01-15 | 세다르스-신나이 메디칼 센터 | 장 및 방광의 운동 장애 및 섬유근육통의 진단 및 치료 |
| CN106999477B (zh) * | 2014-06-30 | 2020-04-10 | 萨利克斯药品公司 | 用于重复治疗肠易激综合征(ibs)的方法 |
| CN105477624A (zh) * | 2015-12-16 | 2016-04-13 | 官键 | 一种用于治疗放射性直肠炎的药物组合物 |
| RU2618452C1 (ru) * | 2015-12-28 | 2017-05-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) | Способ прогнозирования энтерита |
| AU2018212924A1 (en) | 2017-01-30 | 2019-07-04 | Cedars-Sinai Medical Center | Diagnosis of scleroderma |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0858804A1 (de) * | 1997-02-14 | 1998-08-19 | ALFA WASSERMANN S.p.A. | Verwendung von Rifaximin zur Behandlung von durch Cryptosporidie verursachten Diarrhöen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| IT1199374B (it) | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
| US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| JP5844961B2 (ja) * | 2006-08-02 | 2016-01-20 | サリックス ファーマシューティカルズ， インコーポレイテッド | 放射線直腸ｓ状結腸炎を処置するための組成物および方法 |
-
2007
- 2007-08-02 JP JP2009522891A patent/JP5844961B2/ja not_active Expired - Fee Related
- 2007-08-02 SI SI200731674T patent/SI2054066T1/sl unknown
- 2007-08-02 KR KR1020157027021A patent/KR20150132214A/ko not_active Ceased
- 2007-08-02 ES ES07836488.2T patent/ES2538478T3/es active Active
- 2007-08-02 EP EP07836488.2A patent/EP2054066B1/de not_active Not-in-force
- 2007-08-02 CN CN201410562207.8A patent/CN104382900A/zh active Pending
- 2007-08-02 AU AU2007281413A patent/AU2007281413B2/en not_active Ceased
- 2007-08-02 CA CA2659874A patent/CA2659874C/en active Active
- 2007-08-02 PT PT78364882T patent/PT2054066E/pt unknown
- 2007-08-02 DK DK07836488.2T patent/DK2054066T3/en active
- 2007-08-02 HU HUE07836488A patent/HUE025306T2/hu unknown
- 2007-08-02 KR KR1020097003840A patent/KR20090047490A/ko not_active Ceased
- 2007-08-02 MX MX2009001342A patent/MX2009001342A/es unknown
- 2007-08-02 WO PCT/US2007/017379 patent/WO2008016708A2/en not_active Ceased
- 2007-08-02 BR BRPI0714724A patent/BRPI0714724A8/pt not_active Application Discontinuation
- 2007-08-02 PL PL07836488T patent/PL2054066T3/pl unknown
-
2009
- 2009-02-02 IL IL196843A patent/IL196843A/en active IP Right Grant
-
2013
- 2013-08-12 JP JP2013167357A patent/JP2013227350A/ja not_active Withdrawn
-
2015
- 2015-09-11 JP JP2015179596A patent/JP5993074B2/ja not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0858804A1 (de) * | 1997-02-14 | 1998-08-19 | ALFA WASSERMANN S.p.A. | Verwendung von Rifaximin zur Behandlung von durch Cryptosporidie verursachten Diarrhöen |
Non-Patent Citations (6)
| Title |
|---|
| BENSON III A B ET AL: "Recommended guidelines for the treatment of cancer treatment-induced diarrhea", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, vol. 22, no. 14, 1 January 2004 (2004-01-01), pages 2918 - 2926, XP008129343, ISSN: 0732-183X * |
| DANIELSSON A ET AL: "CHRONIC DIARRHEA AFTER RADIOTHERAPY FOR GYNECOLOGICAL CANCER OCCURRENCE AND ETIOLOGY", GUT, vol. 32, no. 10, 1991, pages 1180 - 1187, XP008129781, ISSN: 0017-5749 * |
| GIONCHETTI P ET AL: "Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, BLACKWELL SCIENTIFIC PUBLICATIONS LTD., CAMBRIDGE, GB, vol. 13, no. 6, 1 June 1999 (1999-06-01), pages 713 - 718, XP009110052, ISSN: 0269-2813, DOI: 10.1046/J.1365-2036.1999.00553.X * |
| MANFREDI R: "Enteric infections and related diseases: Focus on rifaximin", TRENDS IN MEDICINE 200507 IT, vol. 5, no. 3, July 2005 (2005-07-01), pages 157 - 167, XP008129311, ISSN: 1594-2848 * |
| RIZZELLO F ET AL: "Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalamine", DIGESTIVE AND LIVER DISEASE SUPPLEMENTS; INTERNATIONAL MEETING ON INFLAMMATORY BOWEL DISEASES; CAPRI, ITALY; JUNE 18-21, 2000,, vol. 32, no. supplement 1, 1 May 2000 (2000-05-01), pages A37, XP008129308, ISSN: 1594-5804, [retrieved on 20031204], DOI: 10.1016/S1590-8658(00)80193-0 * |
| See also references of WO2008016708A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2538478T3 (es) | 2015-06-22 |
| AU2007281413A1 (en) | 2008-02-07 |
| JP5844961B2 (ja) | 2016-01-20 |
| CA2659874A1 (en) | 2008-02-07 |
| BRPI0714724A2 (pt) | 2015-07-07 |
| CA2659874C (en) | 2016-10-11 |
| EP2054066A2 (de) | 2009-05-06 |
| JP2009545602A (ja) | 2009-12-24 |
| WO2008016708A2 (en) | 2008-02-07 |
| JP2013227350A (ja) | 2013-11-07 |
| HUE025306T2 (hu) | 2016-01-28 |
| AU2007281413B2 (en) | 2013-10-31 |
| SI2054066T1 (sl) | 2015-08-31 |
| PL2054066T3 (pl) | 2015-12-31 |
| WO2008016708A3 (en) | 2008-06-19 |
| CN104382900A (zh) | 2015-03-04 |
| DK2054066T3 (en) | 2015-06-08 |
| JP5993074B2 (ja) | 2016-09-14 |
| KR20150132214A (ko) | 2015-11-25 |
| KR20090047490A (ko) | 2009-05-12 |
| BRPI0714724A8 (pt) | 2018-04-10 |
| HK1130199A1 (en) | 2009-12-24 |
| JP2016028079A (ja) | 2016-02-25 |
| IL196843A0 (en) | 2009-11-18 |
| PT2054066E (pt) | 2015-07-16 |
| EP2054066B1 (de) | 2015-04-15 |
| IL196843A (en) | 2016-03-31 |
| MX2009001342A (es) | 2009-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1863507A4 (de) | Zusammensetzungen und verfahren zur behandlung von akne | |
| BRPI0909541A2 (pt) | ''método para tratamento de doenças inflamatórias do cólon'' | |
| EP2223788A4 (de) | Hinterschnittverarbeitungsmechanismus | |
| EP1938085A4 (de) | Kammer zur behandlung mit ultraviolettem licht | |
| EP2243448A4 (de) | Vorrichtung für automatisierte harnverarbeitung | |
| DK2144859T3 (da) | System til behandling af organisk affald ved hjælp af insektlarver | |
| EP1984081A4 (de) | Oxidatives behandlungsverfahren | |
| EP1983965A4 (de) | Fotodynamisches kosmetikverfahren und heilungsverfahren | |
| EP1996021A4 (de) | Zusammensetzungen und verfahren zur behandlung von durch zelluläre proliferation und angiogenese vermittelten leiden | |
| EP2028937A4 (de) | Behandlung mit melatoninagonisten | |
| FR2917299B1 (fr) | Procede et dispositif de traitement cosmetique de la peau par la lumiere | |
| EP1991230A4 (de) | Verfahren zur behandlung von krebs | |
| EP1815198A4 (de) | Verfahren zur behandlung von biomassenrohstoffen | |
| EP2067539A4 (de) | Verfahren zur behandlung von asbestos | |
| PT2099446E (pt) | Método de tratamento de doença inflamatória intestinal | |
| EP1819639A4 (de) | Zerstäubendes behandlungsverfahren | |
| EP1969117A4 (de) | Verfahren zur behandlung einer vorzeitigen ejakulation beim menschen | |
| BRPI0912043A2 (pt) | métodos de tratamento de doença associada à cinesina meiótica | |
| FR2876047B1 (fr) | Traitement de polluants par phytolixiviation | |
| FR2943537B1 (fr) | Traitement des nevrites vestibulaires par l'acetyl-l-leucine | |
| EP1988060A4 (de) | Verfahren zur behandlung von abwasser | |
| EP2229137A4 (de) | Topische zusammensetzungen mit desthiobiotin und derivaten davon sowie hautbehandlungsverfahren | |
| FR2904248B1 (fr) | Procede de traitement bio-assiste d'un sol contamine par des hydrocarbures. | |
| BRPI0915130A2 (pt) | derivado de ácido 7h-indolo{2,1-a]{2]-benzapina-10-carboxílico para o tratamento de hepatite c | |
| FR2910300B1 (fr) | Procede de traitement de la peau par application de composes silicones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090302 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1130199 Country of ref document: HK |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20101203 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 1/00 20060101ALI20101129BHEP Ipc: A61P 1/12 20060101ALI20101129BHEP Ipc: A61K 31/437 20060101ALI20101129BHEP Ipc: A61K 31/7056 20060101AFI20090312BHEP |
|
| 17Q | First examination report despatched |
Effective date: 20111220 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20141028 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 721566 Country of ref document: AT Kind code of ref document: T Effective date: 20150515 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602007041091 Country of ref document: DE Effective date: 20150528 |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20150602 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2538478 Country of ref document: ES Kind code of ref document: T3 Effective date: 20150622 |
|
| RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: SALIX PHARMACEUTICALS, INC. |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602007041091 Country of ref document: DE Owner name: SALIX PHARMACEUTICALS, INC., RALEIGH, US Free format text: FORMER OWNER: SALIX PHARMACEUTICALS, INC., MORRISVILLE, N.C., US |
|
| REG | Reference to a national code |
Ref country code: RO Ref legal event code: EPE |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: RENTSCH PARTNER AG, CH Ref country code: CH Ref legal event code: PCOW Free format text: NEW ADDRESS: 8510 COLONNADE CENTER DRIVE, 27615 RALEIGH NC (US) |
|
| REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20150608 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: EE Ref legal event code: FG4A Ref document number: E010642 Country of ref document: EE Effective date: 20150428 |
|
| REG | Reference to a national code |
Ref country code: SK Ref legal event code: T3 Ref document number: E 18971 Country of ref document: SK |
|
| REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20150401460 Country of ref document: GR Effective date: 20150901 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1130199 Country of ref document: HK |
|
| REG | Reference to a national code |
Ref country code: PL Ref legal event code: T3 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007041091 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E025306 Country of ref document: HU |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| 26N | No opposition filed |
Effective date: 20160118 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150415 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 721566 Country of ref document: AT Kind code of ref document: T Effective date: 20150415 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150415 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150415 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: NEW ADDRESS: BELLERIVESTRASSE 203 POSTFACH, 8034 ZUERICH (CH) |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20180619 Year of fee payment: 12 Ref country code: BG Payment date: 20180627 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20180803 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: EE Payment date: 20180806 Year of fee payment: 12 Ref country code: RO Payment date: 20180719 Year of fee payment: 12 Ref country code: NL Payment date: 20180730 Year of fee payment: 12 Ref country code: IT Payment date: 20180814 Year of fee payment: 12 Ref country code: LT Payment date: 20180719 Year of fee payment: 12 Ref country code: FR Payment date: 20180718 Year of fee payment: 12 Ref country code: IE Payment date: 20180726 Year of fee payment: 12 Ref country code: ES Payment date: 20180903 Year of fee payment: 12 Ref country code: DE Payment date: 20180716 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SK Payment date: 20180724 Year of fee payment: 12 Ref country code: IS Payment date: 20180717 Year of fee payment: 12 Ref country code: LV Payment date: 20180809 Year of fee payment: 12 Ref country code: SI Payment date: 20180725 Year of fee payment: 12 Ref country code: BE Payment date: 20180817 Year of fee payment: 12 Ref country code: TR Payment date: 20180720 Year of fee payment: 12 Ref country code: HU Payment date: 20180724 Year of fee payment: 12 Ref country code: GR Payment date: 20180727 Year of fee payment: 12 Ref country code: DK Payment date: 20180726 Year of fee payment: 12 Ref country code: AT Payment date: 20180726 Year of fee payment: 12 Ref country code: CZ Payment date: 20180725 Year of fee payment: 12 Ref country code: SE Payment date: 20180810 Year of fee payment: 12 Ref country code: GB Payment date: 20180726 Year of fee payment: 12 Ref country code: CH Payment date: 20180725 Year of fee payment: 12 Ref country code: FI Payment date: 20180726 Year of fee payment: 12 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MM4D Effective date: 20190802 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602007041091 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: EE Ref legal event code: MM4A Ref document number: E010642 Country of ref document: EE Effective date: 20190831 |
|
| REG | Reference to a national code |
Ref country code: FI Ref legal event code: MAE |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20190831 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20190901 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 721566 Country of ref document: AT Kind code of ref document: T Effective date: 20190802 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20190802 |
|
| REG | Reference to a national code |
Ref country code: SI Ref legal event code: KO00 Effective date: 20200310 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: EE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200203 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200305 Ref country code: HU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190803 Ref country code: BG Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200229 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: LV Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: LT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190803 |
|
| REG | Reference to a national code |
Ref country code: SK Ref legal event code: MM4A Ref document number: E 18971 Country of ref document: SK Effective date: 20190802 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: SI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190803 Ref country code: CZ Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200303 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190901 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190831 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20210105 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190803 |
|
| PLAA | Information modified related to event that no opposition was filed |
Free format text: ORIGINAL CODE: 0009299DELT |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| PLAA | Information modified related to event that no opposition was filed |
Free format text: ORIGINAL CODE: 0009299DELT |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R083 Ref document number: 602007041091 Country of ref document: DE |
|
| R26N | No opposition filed (corrected) |
Effective date: 20160118 |
|
| RIN2 | Information on inventor provided after grant (corrected) |
Inventor name: BETTENHAUSEN, DOUG Inventor name: JAHRAUS, CHRISTOPHER |
|
| R26N | No opposition filed (corrected) |
Effective date: 20160118 |
|
| RIN2 | Information on inventor provided after grant (corrected) |
Inventor name: BETTENHAUSEN, DOUG Inventor name: JAHRAUS, CHRISTOPHER |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200203 |
|
| PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: PT Effective date: 20210215 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190901 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190802 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230512 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20240725 Year of fee payment: 18 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20260202 |